CLINICAL_TRIALS ClinicalTrials.gov record update

Double Blind, Randomized Phase III Study to Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04618939
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:56.021806+00:00
Published At: 2020-11-20T00:00:00+00:00
Record Updated At: 2020-11-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diphtheria", "Tetanus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-11-20"
protocolSection.identificationModule.nctId: "NCT04618939"
protocolSection.identificationModule.officialTitle: "Double Blind, Randomized Phase III Study to Evaluate the Immunogenicity and Safety of \u0027BR-TD-1001\u0027 Administered Intramuscularly in Healthy Children"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.